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Background: It has recently been demonstrated that zinc oxide nanoparticles (ZnO NPs) 
induce death of cancerous cells whilst having no cytotoxic effect on normal cells. However, 
there are several issues which need to be resolved before translation of zinc oxide nanoparticles 
into medical use, including lack of suitable biocompatible dispersion protocols and a better 
understanding being needed of the mechanism of their selective cytotoxic action. 
Methods: Nanoparticle dose affecting cell viability was evaluated in a model of proliferating cells 
both experimentally and mathematically. The key issue of selective toxicity of ZnO NPs toward 
proliferating cells was addressed by experiments using a biological model of noncancerous cells, 
ie, mesenchymal stem cells before and after cell differentiation to the osteogenic lineage.
Results: In this paper, we report a biocompatible protocol for preparation of stable aqueous 
solutions of monodispersed zinc oxide nanoparticles. We found that the threshold of intracellular 
ZnO NP concentration required to induce cell death in proliferating cells is 0.4 ± 0.02 mM. 
Finally, flow cytometry analysis revealed that the threshold dose of zinc oxide nanoparticles was 
lethal to proliferating pluripotent mesenchymal stem cells but exhibited negligible cytotoxic 
effects to osteogenically differentiated mesenchymal stem cells.
Conclusion: Results confirm the ZnO NP selective cytotoxic action on rapidly proliferating 
cells, whether benign or malignant.
Keywords: zinc oxide nanoparticles, dispersion, selective cytotoxicity, mesenchymal stem cells
Introduction
Nanomaterials have been the subject of increasing research attention in recent years 
because of their potential biomedical and life science applications. Among the various 
nanomaterials, zinc oxide nanoparticles offer significant benefits, and are used in 
several products and systems, including sunscreens, biosensors, food additives, pig-
ments, rubber manufacture, and electronic materials.1 In the biomedical field, one of 
the most important attributes of these nanoparticles is their antibacterial activity, with 
published reports confirming the efficacy of zinc oxide nanoparticle-based prepara-
tions as prophylactic agents against bacterial infections.2,3 However, to date, there 
have been few reports on the cytotoxicity of zinc oxide nanoparticles to mammalian 
cells, with no clear consensus among scientists on the significance of published 
results. One study reported that zinc oxide particles have minimal effects on the 
viability of primary human T cells at concentrations toxic to both Gram-negative and 
Gram-positive bacteria.4 Other reports suggest that these nanoparticles are nontoxic to 
cultured human dermal fibroblasts,4 but exhibit toxicity towards neuroblastoma cells5 
and vascular endothelial cells,6 and induce apoptosis in neural stem cells.7 It has also International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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been reported that nanoparticle size influences cell viability. 
Jones et al pointed out that zinc oxide particles of 8 nm in size 
were more toxic than larger zinc oxide particles (50–70 nm) 
in Staphylococcus aureus.8 Recently, Hanley et al observed 
that there is an inverse relationship between nanoparticle 
size and cytotoxicity in mammalian cells, as well as nano-
particle size and reactive oxygen species production,9 while 
Deng et al showed that zinc oxide nanoparticles manifested 
dose-dependent, but no size-dependent, toxic effects on 
neural stem cells.7 In our opinion, many of the reported 
studies on zinc oxide nanoparticle toxicity have significant 
limitations for two reasons. Firstly, some reports used zinc 
oxide nanoparticles with different characteristics (size, 
shape, and purity) and, secondly, the dispersion protocols 
used have often been unsuitable for biological use. In large-
scale production of nanoparticles, the as-prepared material 
exists as agglomerates, with sizes of up to hundreds of 
microns. The reason for this is that zinc oxide nanoparticles 
(like all nanomaterials) have high superficial energy, result-
ing in decreased interactions with the environment and an 
intrinsic tendency to clustering in aqueous solutions.   However, 
biological applications involving interactions between nano-
particles and living cells require aqueous dispersion of single 
nanoparticles. Thus, the first requirement for the biomedical 
use of zinc oxide nanoparticles is an effective biocompat-
ible protocol for aqueous dispersion. The current reported 
methods for zinc oxide nanoparticle dispersion with bio-
compatible additives do not ensure monodispersion of the 
nanoparticles,4,7,10,11 resulting in the presence of clusters and 
macroscopic agglomerates. These preclude meaningful inves-
tigation of their interactions with target cells. For example, 
Deng et al investigated the toxicity of zinc oxide nanopar-
ticles (size 10 nm, 30 nm, 60 nm, and 200 nm) which were 
sonicated in phosphate-buffered saline for 30 minutes and 
then in complete medium,7 but the resulting aqueous solution 
contained significant clusters and nondispersed particles. 
Similarly, the aqueous solution used by Zhao et al to evaluate 
the cytotoxicity of these nanoparticles had many zinc oxide 
aggregates.10 Some researchers have suggested surface modi-
fication to improve zinc oxide nanoparticle dispersion.11–13 
Such protocols have usually involved the use of nonbiocom-
patible reagents which were subsequently removed. Other 
authors have proposed de novo synthesis of monodispersed 
zinc oxide nanoparticles. The method consists of hydrolysis 
of zinc acetate in diethylenic glycol.4,14,15 The toxic diethyl-
enic glycol is removed by centrifuging and washing several 
times in ethanol. Although this method enables production 
of monodispersed nanoparticle solutions, protocols which 
avoid the use of toxic materials are preferred for cytotoxicity 
studies. In essence, all approaches currently available either 
produce stable nanoparticle solutions which contain nano-
particle clusters or aqueous   monodispersions with residual 
toxic materials in addition to the nanoparticles.
The primary aim of the present study was to develop a 
protocol for the preparation of biocompatible solutions of 
individually dispersed zinc oxide nanoparticles. This mono-
dispersion protocol enabled us to proceed with the second 
part of the investigation which focused on the cytotoxicity 
of these nanoparticles and mechanisms of cell death. We 
estimated the threshold dose of zinc oxide nanoparticles 
which affects the viability of proliferating cells. The study 
was carried out in a human neuroblastoma cell line which 
can be easily used in a mathematical model.
Finally, we investigated the potential application of 
zinc oxide nanoparticles in medicine as a follow-on from 
the report by Hanley et al that these nanoparticles induce 
toxicity in a cell-specific and proliferation-dependent 
  manner. This group demonstrated that zinc oxide nano-
particles exhibit a strong preferential ability to kill rapidly 
dividing cancerous T cells (28–35×) but not normal cells.14 
A recent report confirmed that these nanoparticles exert a 
cytotoxic effect on human glioma cells, but not on normal 
human astrocytes. Similarly, zinc oxide nanoparticles induce 
cell death in breast and prostate cancer cell lines, but have no 
major cytotoxic effects on normal breast and prostate cells.16 
The mechanisms of toxicity appear to involve the generation 
of reactive oxygen species, with cancerous cells producing 
higher inducible levels than normal cells. In the present 
study, we investigated the proliferation-dependent cyto-
toxicity of zinc oxide nanoparticles in a biological model 
of noncancerous cells.
Materials and methods
Preparation of zinc oxide nanoparticles
Zinc oxide nanoparticles were supplied in highly purified 
form (99.9%) from Nanostructured and Amorphous Mate-
rials Inc, Houston, TX. The production method essentially 
involves synthesis of the nanoparticles by solid vapor 
  deposition.16 These as-produced nanoparticles range between 
90 mm and 200 nm in size.
For dispersion of the nanoparticles, we tested the fol-
lowing biological reagents: polyethylene glycol 8 K (P2139 
Sigma-Aldrich, St Louis, MO), polyethylene glycol 14 K 
(637726 Sigma-Aldrich), poly(ethylenimine) (40872-7 
Sigma-Aldrich), polyvinyl alcohol (363170 Sigma-Aldrich), 
gelatin (48723 Sigma-Aldrich), Pluronic® PF127 (P-2443 International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Sigma-Aldrich), sodium dodecyl sulfate (L4390 Sigma-
  Aldrich), Arabic gum (51200 Sigma-Aldrich), glycine (04055 
Sigma-Aldrich), horse serum (ECS0091D Euroclone), and 
bovine serum albumin (A9418 Sigma-Aldrich).
Briefly, an aqueous solution of biological reagents con-
taining zinc oxide nanoparticles 100 µg/mL was vortexed 
for five minutes. The resulting mixture was sonicated [for 
polyethylene glycol, poly(ethylenimine), polyvinyl alcohol, 
gelatin, PF127, sodium dodecyl sulfate, Arabic gum, glycine] 
in a 20 W sonication bath (AGE Electronica SRL, Italy) or 
magnetically stirred (for horse serum, bovine serum albu-
min) overnight. The mixture was then centrifuged at 900 g 
for 10 minutes at room temperature to remove any residual 
nonsuspended nanoparticles and impurities. The concentra-
tion of the nanoparticles was measured by spectrophotometric 
analysis at the wavelength of 380 nm18 after calibration.
size distribution
Electron imaging was performed with a scanning electron 
microscope (FEI XL20) equipped with energy dispersive 
spectroscopy microanalysis (EDAC model). A drop of the 
solution (concentration 10 µg/mL) was transferred onto 
a silicon substrate and allowed to dry under laminar flux 
overnight at room temperature. The sample was then washed 
with ethanol to remove the excess polymer. The size distribu-
tion of the dried nanoparticles was monitored using image 
analysis software “Image J” (http://rsb.info.nih.gov/ij/). The 
size distribution of the nanoparticles in media was moni-
tored by dynamic light scattering (Malvern Zetasizer ZS9, 
Worcestershire, UK).
cell cultures
A human neuroblastoma cell line (SH-SY5Y) was obtained 
from American Type Culture Collection (Rockville, MD). 
The cells were grown in a complete culture medium 
consisting of a 1:1 mixture of Hams F12 (Lonza, Milan, 
Italy),   Dulbecco’s Modified Eagle’s Medium (DMEM) 
supplemented with 10% heat-inactivated fetal bovine serum 
(Lonza), L-glutamine 2 mM, penicillin 100 IU/mL, and 
streptomycin 100 µg/mL.
Bone marrow cells were collected from the tibia and femur 
of Wistar Furth rats following the Dobson procedure.19 Mesen-
chymal stem cells were cultured in DMEM 85%, with 10% heat-
inactivated fetal bovine serum, L-glutamine 2 mM, penicillin 
100 IU/mL, streptomycin 100 µg/mL, and gentamicin 0.5%.
Osteogenic differentiation was achieved by culturing 
mesenchymal stem cells in DMEM supplemented with 
ascorbic acid 100 µg/mL, beta glycerol phosphate 10 mM, 
and dexamethasone 10-7 M for 14 days. In all experiments, 
mesenchymal stem cells were used at passage number 10–12. 
Cells were maintained at 37°C in a saturated humidity atmo-
sphere containing 95% air with 5% CO2.
MTT and WsT-1 assays
3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyl tetrazolium 
bromide (MTT) and 2-(4-iodophenyl)-3-(4-nitophenyl)-
5-(2,4-disulfophenyl)-2H tetrazolium salt (WST-1) cell 
proliferation assays (BioVision, Mountain View, CA) were 
used to investigate the effect of zinc oxide nanoparticles and 
the surfactant on cell viability.
For the MTT assay, 25 × 103 cells were seeded into each 
well of a 96-well plate and incubated with culture medium 
overnight. The medium was then replaced with fresh medium 
containing zinc oxide nanoparticles. After incubation, the 
nanoparticle-modified medium was replaced with 100 µL 
of medium containing MTT 0.5 mg/mL, and the cells were 
incubated for 3 hours at 37°C and 5% CO2. The medium 
containing MTT was then replaced with 100 µL of dimeth-
ylsulfoxide (Sigma) and left for 10 minutes on a platform 
shaker to solubilize the converted formazan. The absorbance 
was measured on a Versamax microplate reader (Molecular 
Devices, Sunnyvale, CA) at a wavelength of 570 nm with 
background subtracted at 690 nm.
For the WST-1 assay, 25 × 103 cells were seeded into each 
well of a 96-well plate and incubated overnight. The medium 
was then replaced with fresh medium containing zinc oxide 
nanoparticles. After incubation, the cells were added to 10 µL 
of WST-1 solution and incubated for 2 hours. Absorbance was 
measured using the Versamax microplate reader at a wavelength 
of 450 nm with a reference wavelength 650 nm. The results of 
all assays were expressed as a percentage of the control assays 
(ie, cells incubated with normal growth medium).
Production of reactive oxygen species
SH-SY5Y cells were seeded into a 24-well plate and incu-
bated overnight. The cells were then incubated in growth 
medium modified with zinc oxide nanoparticles (15 µg/mL) 
for 6 hours. Production of reactive oxygen species was 
detected using the Image-IT green reactive oxygen species 
detection kit (Invitrogen, Milan, Italy). The assay is based on 
5-(and-6)-carboxy-2’, 7’-dichlorodihydrofluorescein diacetate 
(H2DCFDA), a fluorogenic marker for reactive oxygen species 
in viable cells.20 Tert-butyl hydroperoxide (Invitrogen) was 
used as a positive control.21 A negative control was performed 
with SH-SY5Y cells cultured in normal growth medium.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Flow cytometry
Mesenchymal stem cells or osteocytes (500 × 103) were incu-
bated for 6 hours in cell culture medium modified with zinc 
oxide nanoparticles (20 µg/mL). Cell death was evaluated 
by propidium iodide (81845 Sigma, Milan, Italy) staining. 
Results were expressed as a percentage of cell death over 
the total cell number. Measurement was carried out by a 
BD FACScan flow cytometer (BD Bioscience, San Jose, 
CA). The data were acquired and analyzed with CellQuest 
  software. Before acquisition, adherent cells were washed 
with phosphate-buffered saline, detached by trypsinization, 
and suspended in measuring buffer containing propidium 
iodide 50 µM. A blank (cells incubated with normal cell 
culture medium) was first used as a reference for adjusting 
the voltage controlling forward scatter and side scatter.
Modeling
Mathematical modeling was performed using an algorithm in a 
MATLAB working space (MATLAB software,   version R14).
statistical analysis
Results are expressed as mean ± standard error. Statistical 
significance was assessed by one-way analysis of variance. 
Significance was set at P , 0.001.
Results
Zinc oxide nanoparticle dispersion
Aqueous solutions containing zinc oxide nanoparticles were 
examined after preparation in order to assess the quality of 
the dispersion. Spectrophotometric analysis was performed 
at a wavelength of 380 nm18,22,23 showed that among the tested 
reagents (Arabic gum, polyethylene glycol 8 kDa, polyethylene 
glycol 14 kDa, poly(ethylenimine), polyvinyl alcohol, gelatin, 
Pluronic PF127, sodium dodecyl sulfate, glycine, horse serum, 
and bovine serum albumin), only Arabic gum produced a stable 
and highly concentrated dispersion (Table 1). This dispersion was 
thus chosen for further investigation and biological assays.
The stability of this dispersion was tested for up to 5 days. 
The dispersion remained stable for 10 hours after preparation 
(decrease of concentration ,10%). The size distribution of 
the nanoparticles is shown in Figure 1.   Electron imaging 
confirmed that the nanoparticles were singly dispersed (inset 
of Figure 1) with a size of 160 ± 60 nm.   Figure 2 shows 
the energy dispersive spectroscopy spectrum of the 
  nanoparticles. The peaks at 0.53 and 0.995 keV are those of 
oxygen and zinc, respectively. The peak referring to Si is due 
to the substrate on which the sample was deposited.
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Figure 2 energy dispersive spectroscopy analysis of zinc oxide nanoparticles.
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Figure 1 (A) scanning electron microscope image of monodispersed zinc oxide nanoparticles. (B) size distribution of zinc oxide nanoparticles.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Stability of the dispersion in biological media was 
tested by dynamic light scattering. Nanoparticles dispersed 
in phosphate-buffered saline and DMEM showed a size of 
286.4 ± 63.2 nm and 214.2 ± 27.70 nm, respectively.
cytotoxicity
MTT and WST-1 assays were used to detect the viability 
of cells by measuring formation of a formazan product as 
an index of cellular mitochondrial dehydrogenase activ-
ity. We selected a neuroblastoma cell line (SH-SY5Y) 
as a biological model of proliferating cells. As shown in 
Figure 3, we tested the effect of different zinc oxide nano-
particle concentrations on cell proliferation activity. SH-
SY5Y cells were incubated with the nanoparticle-modified 
medium for 24 hours. This was achieved by diluting the 
initial zinc oxide dispersion (nanoparticle concentration 
100 µg/mL, Arabic gum concentration 5 mg/mL) in cell 
growth medium.
MTT data confirmed that, with concentrations up to 
10 µg/mL, no cell damage was observed in any of the tested 
samples. However, an 85% decrease in cell viability was 
observed when the concentration of zinc oxide nanoparticles 
was increased to 15 µg/mL. The toxic effects became more 
evident (cell viability approaching 20%) when the concentra-
tion of nanoparticles was increased to 20 µg/mL. In sharp 
contrast, Arabic gum did not alter cell viability at any con-
centration tested (data not shown). Cell proliferation assay 
was also performed with a WST-1 kit, which confirmed the 
results seen in Figure 3 (data not shown).
We estimated cell viability at different incubation times in 
order to gather information on the dynamics of the cytotoxic-
ity induced by the nanoparticles. Specifically, we incubated 
SH-SY5Y for 3, 6, 12, and 24 hours with cell culture medium 
modified with zinc oxide nanoparticles at a concentration of 
15 µg/mL (Figure 4). These experiments demonstrated that 
the toxic effects become apparent at 3–6 hours of incubation 
with the nanoparticles.
Published reports have demonstrated that zinc oxide 
nanoparticles induce formation of excess reactive   oxygen 
species resulting in alteration and damage of cellular pro-
teins, DNA, and lipids, which can cause cell death.24–27 
We used carboxy-H2DCFDA fluorescence as a reporter 
of intracellular oxidant production. To study the effect of 
zinc oxide nanoparticles on the induction of reactive oxy-
gen species in SH-SY5Y cells, we selected a dose known 
to affect cell viability (Figures 3 and 4). Specifically, we 
incubated the cells with 15 µg/mL of the nanoparticles for 
6 hours. As shown in Figure 5, the nanoparticles produced 
an increase in reactive oxygen species similar to that in the 
positive control.
Finite element analysis
On the basis of a mathematical model suggested by 
Jin et al,28 an algorithm was developed in a MATLAB 
workspace which predicts the dynamics of zinc oxide 
nanoparticle internalization. In this model, nanoparticle 
internalization is described by an interconnected kinetic 
model able to determine transport rates in the various cel-
lular   compartments. Zinc oxide nanoparticles are presumed 
to be coated by extracellular proteins and to bind to cellular 
receptors. Adsorbed complexes are thus internalized via 
receptor-mediated endocytosis. Specifically, nanoparticles 
(concentration L) are adsorbed on the cell membrane by 
cell surface receptors, Rs, Kf, and Kr, being forward and 
reverse kinetic rates. This causes the surface nanoparticle 
concentration on the membrane Cs to increase. The absorbed 
nanoparticles are then endocytosed in lysosomes (kinetic 
rates Ke) and can be recycled back to the plasma membrane 
with a rate constant of Krec. Ci represents the molar zinc 
concentration inside the lysosome. The equations describing 
the internalization process are:
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Figure 3 MTT cell proliferation assays of sh-sY5Y cells incubated for 24 hours with 
different concentrations of zinc oxide nanoparticles (mean ± standard error, n = 6).
120%
100%
80%
60%
40%
20%
0%
3 h6  h 12 h 24 h
Incubation time with ZnO NPs
C
e
l
l
 
v
i
a
b
i
l
i
t
y
MTT assay
Figure 4 MTT cell proliferation assays of sh-sY5Y cells at different incubation 
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and Rs0 is the initial surface receptor density. Model   parameter 
values were found in literature:28
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Figure 5 Detection of intracellular reactive oxygen species in (A) sh-sY5Y treated with tert-butyl hydroperoxide, a common inducer of reactive oxygen species (positive 
control), (B) SH-SY5Y treated with zinc oxide nanoparticle-modified culture medium (15 µg/mL), (C) sh-sY5Y treated with culture medium added with Arabic gum 0.075%. 
Top images: oxidative stress is represented by green fluorescent cells. Bottom images: bright field. (n = 3). scale bar: 10 µm.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Figure 6 Prediction of the intracellular concentration, ci (M), versus time for the different ZnO NP concentrations by mathematical modeling.
Initial receptor density, Rs0, of SH-SY5Y cells had been 
previously established as 4 × 104.29 In our experimental 
conditions, the cellular density, n, is 25 × 103/L0; cytosolic 
and lysosomal concentrations of zinc are 1 × 10-10 M and 
1 × 10-4 M, respectively.28
Implementation of the previous equations in a   MATLAB 
workspace allowed estimation of the intracellular concen-
tration, ci, versus time for the different zinc oxide nano-
particle concentrations used in the cell growth medium 
(Figure 6).
Flow cytometry
Our experiments confirmed that in a biological model of 
proliferating cells, zinc oxide nanoparticles induced cytotox-
icity through a mechanism involving production of reactive 
oxygen species. In the following experiment, we investigated 
if this behavior was cell-specific and proliferation-dependent, 
as previously suggested for normal and cancerous T cells.14,16 
We selected highly proliferating mesenchymal stem cells 
as the biological model. The advantage of this choice is 
that mesenchymal stem cells can be easily differentiated 
into quiescent osteocytes (G0). We used flow cytometry to 
analyze the interaction of the zinc oxide nanoparticles with 
mesenchymal stem cells and osteocytes. Consistent with 
previous work, the cells were incubated with the nanopar-
ticles at 20 µg/mL for 6 hours. As expected, the nanoparticles 
adversely affected the viability of the mesenchymal stem cells 
but not that of osteocytes, which showed viability similar and 
not statistically significantly different from that of the control 
cultures (Figures 7 and 8).
Discussion
Here we report a simple procedure for obtaining a stable 
biocompatible monodispersion of zinc oxide nanopar-
ticles in Arabic gum. Arabic gum is a natural composite 
polysaccharide largely used to coat several kinds of nano-
particles.30 Spectrophotometric analysis revealed that the 
concentration of nanoparticles approached 100 µg/mL and 
decreased slowly over time. We estimate that the stabil-
ity of the dispersion is 10 hours (decrease of nanoparticle 
concentration below 10%). The mechanism of nanoparticle 
dispersion involves rupture of Van der Waals forces between 
  nanoparticles. The   underlying principle is that the surfactant 
molecules adsorb on the surface of the particles by virtue of 
their amphiphilic nature. In particular, the hydrophobic part 
of these molecules is chemisorbed on the nanoparticle outer International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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surface and these reduce the Van der Waals forces between 
the particles, rendering them soluble in aqueous media. 
The mechanism which avoids nanoparticle reaggregation 
in Arabic gum solution is probably steric. Electron imaging 
performed on a drop of dispersion, after drying, revealed 
that the nanoparticles are singly dispersed, and Arabic gum 
coating increases the nanoparticle diameter by about 10 nm 
(Figure 1). Additionally, energy dispersive spectroscopy 
microanalysis confirmed that the dispersion treatment did 
not alter nanoparticle chemistry (Figure 2). Dynamic light 
scattering analysis performed on zinc oxide nanoparticles 
in biological media (phosphate-buffered saline and DMEM) 
confirmed that the particles were still well dispersed, but the 
size of the AG nanoparticles was notably larger than that of 
the dried particles (220–280 nm and 160 nm, respectively). 
This size may be attributed to the Arabic gum chain attaching 
to the nanoparticle in a hydrated conformation.
Zinc oxide nanoparticle dispersions have already been 
used for cytotoxicity studies. Some published reports indi-
cate that zinc oxide nanoparticles can be toxic to mammalian 
cells.5–7 Hanley et al proposed that the mechanism of zinc 
oxide nanoparticle toxicity involves the generation of reactive 
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oxygen species. These authors also suggested cell-specific 
behavior, with cancer cells producing higher inducible levels 
of reactive oxygen species than their normal counterparts 
following exposure to zinc oxide nanoparticles.17
Our cell proliferation assays performed in a human 
neuroblastoma cell line demonstrate that the cytotoxicity 
induced by zinc oxide nanoparticles is dose-dependent 
(Figure 3). We observed no significant changes in cell 
viability of nanoparticle concentrations of 10 µg/mL. At 
these concentrations, we observed a spurious small increase 
in viability compared with the control due to nanopar-
ticle absorbance at the working wavelength. Cell viability 
dropped significantly at a nanoparticle concentration of 
20 µg/mL, and was associated with production of reactive 
oxygen species (Figure 5).
Based on published work and our own findings, we have 
developed a model of zinc oxide nanoparticle cytotoxicity. 
Essentially the process involves internalization of the nano-
particles via receptor-mediated endocytosis, hydrolysis of the 
nanoparticles via zinc ions within the lysosomes, and release 
of zinc ions into the cytosol (Figure 9).
When zinc oxide nanoparticles are added to growth 
medium, the particles are coated by proteins in the 
medium. Cell surface receptors bind the protein adsorbed 
onto the nanoparticles, and the nanoparticles enter cells 
via   receptor-mediated endocytosis. When nanoparticle-
  containing endosomes fuse with lysosomes, the pH drops dra-
matically, approaching 5. The inset of Figure 9 shows the rate 
of zinc oxide hydrolysis as a function of pH; whereas under 
physiological conditions the fraction hydrolyzed is negligible 
(0.02%), the hydrolysis of zinc oxide is complete at pH 5.75. 
The zinc ions induce lysis of the lysosomal membrane, and 
the ions are released into the cytosol. Cytosolic accumulation 
of zinc ions triggers pathways which ultimately cause cell 
death. Specifically, Xia et al demonstrated that zinc oxide 
dissociation disrupts the cellular homeostasis of zinc, leading 
to lysosomal and mitochondrial damage, and ultimately cell 
death by inhibiting cellular respiration through interference 
with cytochrome bc1 in complex III and with α-ketoglutarate 
dehydrogenase in complex I.24 Other researchers have under-
lined that zinc ion-mediated production of reactive oxygen 
species promotes two important mechanisms, ie, cytoplasmic 
release of calcium ions and interaction with the cytoplasmic 
membrane, causing loss of membrane integrity and leading 
to calcium influx through membrane channels.25
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Figure  8  Zinc  oxide  nanoparticle  toxicity  in  mesenchymal  stem  cells  versus 
osteocytes. cultures were treated with zinc oxide nanoparticles for 6 hours and cell 
viability was determined using flow cytometry and propidium iodide uptake (mean ± 
standard error, n = 4).
Table 1 Dispersion of zinc oxide nanoparticles
Reagent Reagent  
concentration
Dispersion 
method1
Pellet1 NP  
concentration   
(μg/mL)
Peg 8 K 5% Us Y –
Peg 14 K 5% Us Y –
PeI 5% Us N –
PA 5% Us Y –
gelatin 5% Us Y –
PF 127 5% Us Y 10
sDs 5% Us Y –
Ag 5% Us N 100
gLY 5% Us N –
hs 5% Ms Y –
BSA 5% Ms Y –
Note: 1After centrifugation at 900 g. 
Abbreviations: Us, sonication; Ms, magnetic stirring; Peg, polyethylene glycol; PeI, 
poly(ethylenimine); PA, polyvinyl alcohol; PF, Pluronic®; sDs, sodium dodecyl sulfate; 
AG, Arabic gum; GLY, glycine; HS, horse serum; BSA, bovine serum albumin.
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The physiological zinc ion concentration in the cytosol 
ranges from 10-9 to 10-12 mM, whereas the zinc ion 
concentration in lysosomes is about 10-4 mM. Figure 6 shows 
the cytosolic concentration of zinc ions with time for different 
initial concentrations of zinc oxide nanoparticles in growth 
medium. For all curves, the cytosolic concentration of zinc 
ions reaches a plateau within 6 hours of incubation, in agree-
ment with experimental observations (Figure 4).
Figure 5 shows that cell viability starts to decline after 
24 hours of continuous incubation with zinc oxide   nanoparticles 
at concentrations of 10–15 µg/mL, corresponding to intracel-
lular zinc ion levels of 0.38–0.5 mM (Figure 6). Additionally, 
when cells are incubated with zinc oxide nanoparticles at a 
concentration of 15 µg/mL, a decrease in cell viability is 
observed within 3 and 6 hours of incubation, the intracel-
lular zinc ion concentration being 0.3 mM and 0.42 mM, 
respectively (Figure 6). From coupling the previous values, 
we obtained: {0.38;0.5}∩{0.3;0.42} = {0.38;0.42}.
The threshold value of intracellular zinc oxide 
nanoparticles (ie, zinc ion concentration) for induction of 
cell death is thus 0.4 ± 0.02 mM. This information is appli-
cable in principle to a biological model of proliferating cells. 
What about noncancerous cells? And more interestingly, 
what happens if the cell changes its proliferation rate? We 
addressed this question in the last part of the study in which 
we used a natural model of undifferentiated mesenchymal 
stem cells derived from bone marrow with the capacity 
to replicate and differentiate in vitro into several lineages 
including bone, cartilage, stroma, fat, muscle, and tendon. 
The therapeutic potential of mesenchymal stem cells in cell 
therapy for several incurable or debilitating disorders has 
generated considerable interest in the field of regenerative 
medicine.31 Over the last two decades, mesenchymal stem 
cell-based therapy has progressed rapidly from preclinical to 
early clinical Phase I and II studies in a range of human dis-
eases (www.clinicaltrialgov). Osteocytes used in this work 
were obtained via osteogenic differentiation of mesenchymal 
stem cells. These two populations, although biologically 
related, show opposite proliferation rates. We evaluated 
cell death induced by zinc oxide nanoparticles using flow 
cytometry (Figures 7 and 8). In flow cytometry, a single 
wavelength laser beam illuminates each cell and generates 
forward scatter and side scatter signals. Forward scatter cor-
relates with cross-sectional cell area and side scatter reflects 
intracellular complexity, such as membrane roughness, 
nucleus shape, and the amount of cytoplasmic granules. 
Hence, flow cytometry is a powerful tool for investigating 
the interaction between nanoparticles and cells.32 The effect 
of zinc oxide nanoparticles on plasma membrane damage 
was assessed by permeability to propidium iodide. Cells 
were incubated with 20 µg/mL of zinc oxide nanoparticles 
for 6 hours (corresponding to an intracellular zinc concen-
tration of 0.5 mM). We analyzed three experimental groups, 
ie, mesenchymal stem cells (Figures 7A and 7B), osteocytes 
(Figures 7C and 7D), and mesenchymal stem cells/osteo-
cyte cocultures (Figures 7E and 7F). The experimental data 
obtained with the mesenchymal stem cells confirmed the 
behavior   previously observed with human neuroblastoma 
cells, ie, zinc oxide nanoparticles induced cytotoxicity at 
a certain dosage (Figure 8). The same dose of zinc oxide 
nanoparticles added to cultured osteocytes did not induce 
any significant cytotoxic effects (Figure 8). Again, the 
cytotoxicity observed in cocultures seems to overlap with 
the data acquired independently for each single culture 
(Figures 7B, 7D, and 7F). In conclusion, the increased fluo-
rescent intensity in the presence of zinc oxide nanoparticles 
was more significant in mesenchymal stem cells than in the 
differentiated osteogenic lineage. The different behavior 
of the two cell types is likely due to the different cellular 
interaction with zinc oxide nanoparticles rather than to any 
differences in uptake of the nanoparticles. The strong interac-
tion between osteocytes and the nanoparticles is reflected by 
the parallel strong increase of side scatter compared with the 
control cultures, indicative of increased cellular complexity 
due to nanoparticle-cell interaction.32 It has been reported 
that nanomaterials can promote autophagy,33–36 and this could 
be an alternative biological process altering the side scatter 
profile. Because autophagy ultimately causes cell death, the 
negligible cytotoxicity induced by zinc oxide nanoparticles 
on osteocytes (Figure 8) suggests that the alteration in side 
scatter could be a result of interaction with the nanomaterials 
rather than an autophagic process.
Our findings are thus in agreement with the hypothesis that 
the mechanisms of zinc oxide nanoparticle toxicity might be 
related to the proliferative potential of the cell.14,16 The explana-
tion of this lies in the extent of production of reactive oxygen 
species mediated by zinc oxide nanoparticles, this being much 
higher in rapidly pluripotential proliferating cells than in dif-
ferentiated cells. Based on this findings, we confirm that zinc 
oxide nanoparticles have the potential to function as natural 
selective killers of all highly proliferating cells, whether can-
cerous or not. In conclusion, although the application of zinc 
oxide nanoparticles in cancer therapy looks intriguing and 
exciting, specific tumor cell targeting will be essential (eg, by International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
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nanoparticle functionalization with cell ligands) because these 
nanoparticles are killers of all rapidly proliferating cells, irre-
spective of their benign or malignant nature.
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